Skip to content
HowShorted

Fate Therapeutics, Inc. short interest in 2026

In 2026, Fate Therapeutics, Inc.'s disclosed short interest ran from 9.92% of shares outstanding on 15 Jan 2026 to 7.83% on 15 Sep 2026, a change of -2.09 percentage points. The year's high was 9.92% on 15 Jan 2026 and its low 6.28% on 15 Jul 2026, averaging 8.28% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.50 days on 15 Sep 2026. Full history: Fate Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Fate Therapeutics, Inc. in 2026

2026 in figures

Start of year
9.92% (15 Jan 2026)
End of year
7.83% (15 Sep 2026)
Change
-2.09 pp
High
9.92% (15 Jan 2026)
Low
6.28% (15 Jul 2026)
Average
8.28%
Highest days to cover
10.50 (15 Sep 2026)
SEC filings marked
6

Every report in 2026

Fate Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20269.92%7.27
30 Jan 20269.89%5.64
13 Feb 20269.65%7.46
27 Feb 20268.29%5.4710-K filed, results (8-K)
13 Mar 20268.08%6.59
31 Mar 20268.55%6.64
15 Apr 20268.91%8.17
30 Apr 20268.89%9.30
15 May 20268.35%1.9810-Q filed, results (8-K)
29 May 20269.18%2.07
15 Jun 20269.28%2.99
30 Jun 20266.38%1.22
15 Jul 20266.28%1.98
31 Jul 20266.59%4.58
14 Aug 20267.10%3.2810-Q filed, results (8-K)
31 Aug 20267.60%6.23
15 Sep 20267.83%10.50

See also: Fate Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.